TATE GREGAITIS: Open Payments
NPI 1881971216 · GRAND RAPIDS, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$454 in 7 payments from 7 companies in 2025. Trend: 2023 $165 · 2024 $119 · 2025 $454
Food & beverage: $454
| Company | Payments | Amount |
|---|---|---|
| Syndax Pharmaceuticals, Inc. | 1 | $137 |
| AstraZeneca Pharmaceuticals LP | 1 | $125 |
| Janssen Biotech, Inc. | 1 | $90 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $31 |
| Pharmacosmos Therapeutics Inc. | 1 | $28 |
| SOBI, INC | 1 | $23 |
| GENZYME CORPORATION | 1 | $21 |
Products named: REVUFORJ, IMFINZI, TECVAYLI, ICLUSIG, MONOFERRIC, Vonjo, SARCLISA.
Industry payments across MI — which companies pay providers there.
